These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8360326)

  • 1. Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis.
    Noronha A; Toscas A; Jensen MA
    J Neuroimmunol; 1993 Jul; 46(1-2):145-53. PubMed ID: 8360326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-beta 1b treatment decreases tumor necrosis factor-alpha and increases interleukin-6 production in multiple sclerosis.
    Brod SA; Marshall GD; Henninger EM; Sriram S; Khan M; Wolinsky JS
    Neurology; 1996 Jun; 46(6):1633-8. PubMed ID: 8649562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo inhibition of mitogen-driven T-cell activation by recombinant interferon beta.
    Rudick RA; Carpenter CS; Cookfair DL; Tuohy VK; Ransohoff RM
    Neurology; 1993 Oct; 43(10):2080-7. PubMed ID: 8105424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated T lymphocytes regulate hyaluronan binding to monocyte CD44 via production of IL-2 and IFN-gamma.
    Levesque MC; Haynes BF
    J Immunol; 2001 Jan; 166(1):188-96. PubMed ID: 11123292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis.
    Hamamcioglu K; Reder AT
    Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon (IFN)-beta treatment enhances CD95 and interleukin 10 expression but reduces interferon-gamma producing T cells in MS patients.
    Rep MH; Schrijver HM; van Lopik T; Hintzen RQ; Roos MT; Adèr HJ; Polman CH; van Lier RA
    J Neuroimmunol; 1999 Apr; 96(1):92-100. PubMed ID: 10227428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new cell enzyme-linked immunosorbent assay demonstrates gamma interferon suppression by beta interferon in multiple sclerosis.
    Bakhiet M; Ozenci V; Withagen C; Mustafa M; Fredrikson S; Link H
    Clin Diagn Lab Immunol; 1999 May; 6(3):415-9. PubMed ID: 10225846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
    Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
    Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [T-cell interferon-gamma, tumor necrosis factor-alpha and interleukin-6 receptor binding in patients with multiple sclerosis. Effects of interferon-beta-1b treatment].
    Bongioanni P; Romano MR; Boccardi B; Lombardo F; Moscato G; Mosti S; Baldini C; Nuti S; Meucci G; Rossi B
    Rev Neurol; 1999 Nov 16-30; 29(10):893-9. PubMed ID: 10637835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of antibody isotype in IFN-gamma and IL-2 production during anti-CD3-induced T cell proliferation.
    Frenken LA; Koene RA; Tax WJ
    Transplantation; 1991 Apr; 51(4):881-7. PubMed ID: 1826571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production.
    Micallef MJ; Ohtsuki T; Kohno K; Tanabe F; Ushio S; Namba M; Tanimoto T; Torigoe K; Fujii M; Ikeda M; Fukuda S; Kurimoto M
    Eur J Immunol; 1996 Jul; 26(7):1647-51. PubMed ID: 8766574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis.
    Noronha A; Toscas A; Jensen MA
    Ann Neurol; 1992 Jan; 31(1):103-6. PubMed ID: 1371908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dependent cytokine deviation toward the Th2 side in Japanese multiple sclerosis patients with interferon beta-1b.
    Ochi H; Feng-Jun M; Osoegawa M; Minohara M; Murai H; Taniwaki T; Kira J
    J Neurol Sci; 2004 Jul; 222(1-2):65-73. PubMed ID: 15240198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation by interleukin 2 of interleukin 2 receptors and gamma-interferon synthesis by human thymocytes: augmentation of interleukin 2 receptors by interleukin 2.
    Reem GH; Yeh NH
    J Immunol; 1985 Feb; 134(2):953-8. PubMed ID: 2981271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diminished production of type-I interferons and interleukin-2 in patients with multiple sclerosis.
    Wandinger KP; Wessel K; Neustock P; Siekhaus A; Kirchner H
    J Neurol Sci; 1997 Jul; 149(1):87-93. PubMed ID: 9168171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-gamma secretion by peripheral blood T-cell subsets in multiple sclerosis: correlation with disease phase and interferon-beta therapy.
    Becher B; Giacomini PS; Pelletier D; McCrea E; Prat A; Antel JP
    Ann Neurol; 1999 Feb; 45(2):247-50. PubMed ID: 9989628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins as immunomodulators: comparison with interferon-beta 1b in MS.
    Neuhaus O; Strasser-Fuchs S; Fazekas F; Kieseier BC; Niederwieser G; Hartung HP; Archelos JJ
    Neurology; 2002 Oct; 59(7):990-7. PubMed ID: 12370451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline T cell reactivity in multiple sclerosis is correlated to efficacy of interferon-beta.
    Killestein J; Hintzen RQ; Uitdehaag BM; Baars PA; Roos MT; van Lier RA; Polman CH
    J Neuroimmunol; 2002 Dec; 133(1-2):217-24. PubMed ID: 12446026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon beta induces T-helper 2 immune deviation in MS.
    Kozovska ME; Hong J; Zang YC; Li S; Rivera VM; Killian JM; Zhang JZ
    Neurology; 1999 Nov; 53(8):1692-7. PubMed ID: 10563614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.